Friday, October 2, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1semaglutidecardiovascularnovo nordisk

Medscape reports semaglutide heart benefits with mechanism still unclear

The cardiovascular effect does not appear fully explained by weight loss, leaving the underlying pathway an open question.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 1 09:59 ETSource: Medscape

The wire

  1. 01Medscape reports that semaglutide delivers cardiovascular benefits whose mechanism remains unexplained.
  2. 02Clinicians prescribing semaglutide for cardiometabolic indications face patient questions about how the heart benefit arises.
  3. 03The mechanism is unresolved; the item summarizes existing discussion rather than reporting a new trial readout.

From the source

Semaglutide Offers Heart Benefits, Mechanism Remains Unclear

Read at medscape.com
PeptiPrescribed peptides from $99/moSee all →